Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | RET | P07949 | 1/20 | 0.30 |
| ▸ | KIF5B | P33176 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | SMPD3 | Q9NY59 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30559672 | 1.00 | PDPK1 (0.38) | PDPK1HSD17B10MAPTALDH1A1MEN1 | |
| SCHEMBL14326156 | 0.79 | PDPK1 (0.39) | PDPK1HSD17B10MAPTALDH1A1MEN1 | |
| SCHEMBL2059421 | 0.77 | — | — | |
| SCHEMBL12051534 | 0.76 | PDPK1 (0.41) | PDPK1HSD17B10MAPTALDH1A1MEN1 | |
| SCHEMBL30559714 | 0.76 | ALDH1A1 (0.38) | PDPK1HSD17B10MAPTALDH1A1MEN1 | |
| SCHEMBL23717803 | 0.73 | PDPK1 (0.38) | PDPK1HSD17B10MAPTALDH1A1MEN1 | |
| SCHEMBL4097046 | 0.73 | PDPK1 (0.38) | PDPK1HSD17B10MAPTALDH1A1MEN1 | |
| SCHEMBL30636105 | 0.73 | PDPK1 (0.38) | PDPK1HSD17B10MAPTALDH1A1MEN1 | |
| SCHEMBL28496069 | 0.73 | PDPK1 (0.38) | PDPK1HSD17B10MAPTALDH1A1MEN1 | |
| SCHEMBL12348218 | 0.73 | TDP1 (0.34) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118146056-A | Catalytic synthesis method of nitrogen-containing aromatic heterocyclic chlorinated organic compound | 河北威远生物化工有限公司 | 2024-06-07 | — | — | CN | disclosed |
| US-20130079319-A1 | CEPHEM COMPOUND HAVING PSEUDO-CATECHOL GROUP | SHIONOGI & CO., LTD. (JP) | 2013-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079319-A1 | CEPHEM COMPOUND HAVING PSEUDO-CATECHOL GROUP | CENPE, CCNE2, CEP170 | PDPK1 4788/4885HSD17B10 2332/4885MAPT 2042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.